Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SmithKline Feosol recall

This article was originally published in The Tan Sheet

Executive Summary

Potential for Feosol Elixir Iron Supplement Therapy to crystallize inside plastic bottles, thereby reducing its strength, prompted SmithKline Beecham to initiate a recall of nearly 11,000 units distributed across the U.S. There have been no consumer complaints. While the distribution of the liquid in plastic bottles has been suspended, Feosol caplets and tablets will remain on the market. SmithKline switched from glass bottles last year. FDA has not yet classified the recall, filed in early February, but SB said the product does not present a health threat
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS090911

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel